5-methoxytryptamine has been researched along with Cognition Disorders in 1 studies
5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Compton, DM | 1 |
| Dietrich, KL | 1 |
| Selinger, MC | 1 |
| Testa, EK | 1 |
1 other study available for 5-methoxytryptamine and Cognition Disorders
| Article | Year |
|---|---|
5-methoxy-N,N-di(iso)propyltryptamine hydrochloride (Foxy)-induced cognitive deficits in rat after exposure in adolescence.
Topics: 5-Methoxytryptamine; Age Factors; Animals; Cognition Disorders; Hallucinogens; Male; Maze Learning; | 2011 |